rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Shoulder Innovations, Inc.

SI · NYSE

Health CareMedical DevicesJust started moving

SI stood above a rising 150-day average in 25 of the last 29 weekly readings, including each of the last 3 weeks. It is 1.9% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
3 in a row
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$293K
Insider sales, 12 months
$10.9M
Officials’ trades on record
6
Institutions holding
73 (+17)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 25 of 29 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$6.9M$0$11.0MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

6 disclosed lines: House 3, Senate 3, executive 0; 3 people.

WhoDidAmountTraded
Chris Jacobs House: U.S. House ClerkNY27sold$1k–$15k8 Nov 2022filed 12 Dec 2022
Chris Jacobs House: U.S. House ClerkNY27bought$1k–$15k18 Jul 2022filed 9 Sep 2022
Thomas R. Carper Senate: U.S. Senate eFDSenatorboughtspouse$1k–$15k31 Jan 2022filed 3 Feb 2022
Thomas R. Carper Senate: U.S. Senate eFDSenatorboughtspouse$1k–$15k20 Nov 2020filed 17 May 2021
Thomas R. Carper Senate: U.S. Senate eFDSenatorboughtspouse$1k–$15k20 Nov 2020filed 2 Dec 2020
Rubén Hinojosa House: U.S. House ClerkTX15sold$1k–$15k20 Sep 2013filed 15 Apr 2015

Insiders

Buy orders, 12 months7
Sale orders, 12 months15
Buyers · sellers3 · 3
WhoDidSharesTraded
Robert Joseph BallCEO & Executive Chairmansold10,175at $18.4514 Sep 2026filed 14 Sep 2026
Gilde Healthcare Holding B.v.10% ownersold1,196at $22.6026 Aug 2026filed 28 Aug 2026
Gilde Healthcare Holding B.v.10% ownersold681at $22.6224 Aug 2026filed 24 Aug 2026
Gilde Healthcare Holding B.v.10% ownersold20,516at $22.6121 Aug 2026filed 24 Aug 2026
Gilde Healthcare Holding B.v.10% ownersold3,900at $22.6020 Aug 2026filed 24 Aug 2026
Matthew Fraser AhearnChief Operating Officersold12,586at $20.9418 Aug 2026filed 18 Aug 2026
Matthew Fraser AhearnChief Operating Officersold1,600at $21.3818 Aug 2026filed 18 Aug 2026
Matthew Fraser AhearnChief Operating Officersold8,314at $20.1017 Aug 2026filed 18 Aug 2026
Gilde Healthcare Holding B.v.10% ownersold2,095at $22.606 Aug 2026filed 7 Aug 2026
Gilde Healthcare Holding B.v.10% ownersold7,338at $22.645 Aug 2026filed 7 Aug 2026
Gilde Healthcare Holding B.v.10% ownersold99,812at $22.774 Aug 2026filed 5 Aug 2026
Gilde Healthcare Holding B.v.10% ownersold10,751at $22.713 Aug 2026filed 5 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders73+17 on the quarter
New · exited27 · 10
Reported value$168.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FMR LLCreduced · filed 13 Aug 20263,673,960$74.5M-110,592−2.9%
BlackRock, Inc.added · filed 7 Aug 2026638,420$12.9M+82,368+14.8%
SECTORAL ASSET MANAGEMENT INCunchanged · filed 14 Aug 2026430,407$8.7M00.0%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026392,181$8.0M-21,299−5.2%
KCM Capital Incadded · filed 12 Aug 2026300,000$6.1M+265,000+757.1%
TimesSquare Capital Management, LLCreduced · filed 7 Aug 2026298,219$6.0M-24,545−7.6%
Roubaix Capital, LLCreduced · filed 10 Aug 2026255,288$5.2M-1,833−0.7%
Driehaus Capital Management LLCnew · filed 14 Aug 2026253,760$5.1M+253,760
Parkman Healthcare Partners LLCnew · filed 14 Aug 2026226,212$4.6M+226,212
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026199,529$4.0M+15,850+8.6%
30 Sep 2025 – 30 Jun 2026
425772Sep 25Dec 25Mar 26Jun 26

Everyone who traded it

Andrew Hykes Company insiderDirector · last 5 Oct 20260 · 0
Casey M. Tansey Company insiderDirector, 10% owner · last 5 Oct 20261 · 0
Kevin K. Sidow Company insiderDirector · last 5 Oct 20260 · 0
Paul Buckman Company insiderDirector · last 5 Oct 20260 · 0
Robert Joseph Ball Company insiderCEO & Executive Chairman · last 14 Sep 20265 · 1
Gilde Healthcare Holding B.V. Company insider10% owner · last 26 Aug 20261 · 10
Matthew Fraser Ahearn Company insiderChief Operating Officer · last 18 Aug 20260 · 4
Richard Buchholz Company insiderDirector · last 26 Jun 20262 · 0
Jeffrey S. Points Company insiderChief Financial Officer · last 13 Mar 20265 · 0
David Lawrence Blue Company insiderOfficer · last 30 Jan 20260 · 0
Geoffrey B. Pardo Company insiderDirector, 10% owner · last 1 Aug 20251 · 0
Lightstone Ventures Ii (A), L.p. Company insiderOther · last 1 Aug 20251 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202576.5%
Operating profit marginFY 2025 · to 31 Dec 2025-55.6%
Free cash flow marginFY 2025 · to 31 Dec 2025-76.1%
Return on capital employedFY 2025 · to 31 Dec 2025-16.9%
Debt to equityFY 2025 · to 31 Dec 20250.11×
Research spendFY 2025 · to 31 Dec 202516.3%
Share count trendFY 2025 · to 3 Mar 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$26.9M
Free cash flowFY 2025 · to 31 Dec 2025−$36.0M

Analyst forecasts

No analyst forecasts yet.